Associations between thyroid hormones and serum metabolite profiles in an euthyroid population

Metabolomics

Volumn 10, Issue 1, 2014, Pages 152-164

  Jourdan, Carolin ^a   Linseisen, Jakob ^a   Meisinger, Christa ^a   Petersen, Ann Kristin ^a   Gieger, Christian ^a   Rawal, Rajesh ^a   Illig, Thomas ^a,b   Heier, Margit ^a   Peters, Annette ^a   Wallaschofski, Henri ^c   Nauck, Matthias ^c   Kastenmüller, Gabi ^a   Suhre, Karsten ^a,d   Prehn, Cornelia ^a   Adamski, Jerzy ^a,e   Koenig, Wolfgang ^f   Roden, Michael ^g   Wichmann, H Erich ^a,h,i   Völzke, Henry ^c  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF GREIFSWALD   (Germany)

^d WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF ULM   (Germany)

^g LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^h UNIVERSITY OF MUNICH   (Germany)

ⁱ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Epidemiology; Free thyroxine; Serum metabolites; Targeted metabolomics; Thyroid hormones; Thyrotropin

Indexed keywords

ACETYLCARNITINE; ACYLCARNITINE; ALANINE AMINOTRANSFERASE; AMINO ACID; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATININE; CYSTATIN C; GAMMA GLUTAMYLTRANSFERASE; INSULIN; PHOSPHATIDYLCHOLINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; BODY MASS; ELECTROSPRAY MASS SPECTROMETRY; ENZYME IMMUNOASSAY; EUTHYROIDISM; FATTY ACID OXIDATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; KIDNEY FUNCTION; LEUKOCYTE COUNT; LIVER FUNCTION; MALE; METABOLITE; OBESITY; PHYSICAL ACTIVITY;

EID: 84892485053     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-013-0563-4     Document Type: Article

References (48)

1. Altmaier, E., Kastenmuller, G., Romisch-Margl, W., Thorand, B., Weinberger, K. M., Adamski, J., et al. (2009). Variation in the human lipidome associated with coffee consumption as revealed by quantitative targeted metabolomics. Molecular Nutrition & Food Research, 53(11), 1357-1365.
2. Altmaier, E., Kastenmuller, G., Romisch-Margl, W., Thorand, B., Weinberger, K. M., Illig, T., et al. (2011). Questionnaire-based self-reported nutrition habits associate with serum metabolism as revealed by quantitative targeted metabolomics. European Journal of Epidemiology, 26(2), 145-156.
3. Altmaier, E., Ramsay, S. L., Graber, A., Mewes, H. W., Weinberger, K. M., & Suhre, K. (2008). Bioinformatics analysis of targeted metabolomics-uncovering old and new tales of diabetic mice under medication. Endocrinology, 149(7), 3478-3489.
4. Assfalg, M., Bertini, I., Colangiuli, D., Luchinat, C., Schafer, H., Schutz, B., et al. (2008). Evidence of different metabolic phenotypes in humans. Proceedings of the National Academy of Sciences of the United States of America, 105(5), 1420-1424.
5. Biondi, B. (2012a). Mechanisms in endocrinology: heart failure and thyroid dysfunction. European Journal of Endocrinology, 167(5), 609-618.
6. Biondi, B. (2012b). Natural history, diagnosis and management of subclinical thyroid dysfunction. Best Practice and Research Clinical Endocrinology and Metabolism, 26(4), 431-446.
7. Biondi, B., Palmieri, E. A., Lombardi, G., & Fazio, S. (2002). Subclinical hypothyroidism and cardiac function. Thyroid, 12(6), 505-510.
8. Boelaert, K., & Franklyn, J. A. (2005). Thyroid hormone in health and disease. Journal of Endocrinology, 187(1), 1-15.
9. Brabant, G., Beck-Peccoz, P., Jarzab, B., Laurberg, P., Orgiazzi, J., Szabolcs, I., et al. (2006). Is there a need to redefine the upper normal limit of TSH? European Journal of Endocrinology, 154(5), 633-637.
10. Brix, K., Fuhrer, D., & Biebermann, H. (2011). Molecules important for thyroid hormone synthesis and action-known facts and future perspectives. Thyroid Research, 4(Suppl 1), S9.
11. Clement, K., Viguerie, N., Diehn, M., Alizadeh, A., Barbe, P., Thalamas, C., et al. (2002). In vivo regulation of human skeletal muscle gene expression by thyroid hormone. Genome Research, 12(2), 281-291.
12. Demers, L. M., & Spencer, C. A. (2003). Laboratory Support for the diagnosis and monitoring of thyroid disease. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines. Washington: National Academy of Clinical Biochemistry.
13. Dumas, M. E., Wilder, S. P., Bihoreau, M. T., Barton, R. H., Fearnside, J. F., Argoud, K., et al. (2007). Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models. Nature Genetics, 39(5), 666-672.
14. Fazio, S., Palmieri, E. A., Lombardi, G., & Biondi, B. (2004). Effects of thyroid hormone on the cardiovascular system. Recent Progress in Hormone Research, 59, 31-50.
15. Flamant, F., Gauthier, K., & Samarut, J. (2007). Thyroid hormones signaling is getting more complex: STORMs are coming. Molecular Endocrinology, 21(2), 321-333.
16. Goek, O. N., Doring, A., Gieger, C., Heier, M., Koenig, W., Prehn, C., et al. (2012). Serum metabolite concentrations and decreased GFR in the general population. American Journal of Kidney Diseases, 60(2), 197-206.
17. Holle, R., Happich, M., Lowel, H., & Wichmann, H. E. (2005). KORA-a research platform for population based health research. Gesundheitswesen, 67(Suppl 1), S19-S25.
18. Illig, T., Gieger, C., Zhai, G., Romisch-Margl, W., Wang-Sattler, R., Prehn, C., et al. (2010). A genome-wide perspective of genetic variation in human metabolism. Nature Genetics, 42(2), 137-141.
19. Jourdan, C., Petersen, A. K., Gieger, C., Doring, A., Illig, T., Wang-Sattler, R., et al. (2012). Body fat free mass is associated with the serum metabolite profile in a population-based study. PLoS One, 7(6), e40009.
20. Kaptein, E. M., Beale, E., & Chan, L. S. (2009). Thyroid hormone therapy for obesity and nonthyroidal illnesses: a systematic review. Journal of Clinical Endocrinology and Metabolism, 94(10), 3663-3675.
21. Kim, B. (2008). Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid, 18(2), 141-144.
22. Knudsen, N., Jorgensen, T., Rasmussen, S., Christiansen, E., & Perrild, H. (1999). The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clinical Endocrinology (Oxf), 51(3), 361-367.
23. Krug, S., Kastenmuller, G., Stuckler, F., Rist, M. J., Skurk, T., Sailer, M., et al. (2012). The dynamic range of the human metabolome revealed by challenges. FASEB Journal, 26(6), 2607-2619.
24. Kyle, U. G., Genton, L., Karsegard, L., Slosman, D. O., & Pichard, C. (2001). Single prediction equation for bioelectrical impedance analysis in adults aged 20-94 years. Nutrition, 17(3), 248-253.
25. Meisinger, C., Lowel, H., Heier, M., Kandler, U., & Doring, A. (2007). Association of sports activities in leisure time and incident myocardial infarction in middle-aged men and women from the general population: the MONICA/KORA Augsburg cohort study. European Journal of Cardiovascular Prevention and Rehabilitation, 14(6), 788-792.
26. Moreno, M., de Lange, P., Lombardi, A., Silvestri, E., Lanni, A., & Goglia, F. (2008). Metabolic effects of thyroid hormone derivatives. Thyroid, 18(2), 239-253.
27. Nimptsch, K., Berg-Beckhoff, G., & Linseisen, J. (2010). Effect of dietary fatty acid intake on prospective weight change in the Heidelberg cohort of the European prospective investigation into cancer and nutrition. Public Health Nutrition, 13(10), 1636-1646.
28. Pande, S. V. (1975). A mitochondrial carnitine acylcarnitine translocase system. Proceedings of the National Academy of Sciences of the United States of America, 72(3), 883-887.
29. Panicker, V., Wilson, S. G., Walsh, J. P., Richards, J. B., Brown, S. J., Beilby, J. P., et al. (2010). A locus on chromosome 1p36 is associated with thyrotropin and thyroid function as identified by genome-wide association study. American Journal of Human Genetics, 87(3), 430-435.
30. Paternoster, R., Brame, R., Mazerolle, P., & Piquero, A. (1998). Using the correct statistical test for the equality of regression coefficients. Criminology, 36(4), 859-866.
31. Psychogios, N., Hau, D. D., Peng, J., Guo, A. C., Mandal, R., Bouatra, S., et al. (2011). The human serum metabolome. PLoS One, 6(2), e16957.
32. Ribeiro, R. C., Apriletti, J. W., Wagner, R. L., West, B. L., Feng, W., Huber, R., et al. (1998). Mechanisms of thyroid hormone action: insights from X-ray crystallographic and functional studies. Recent Progress in Hormone Research, 53, 351-392. discussion 392-354.
33. Römisch-Margl, W., Prehn, C., Bogumil, R., Röhring, C., Suhre, K., & Adamski, J. (2011). Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics. Metabolomics, 1-10.
34. Roschinger, W., Muntau, A. C., Duran, M., Dorland, L., IJIst, L., Wanders, R. J., et al. (2000). Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle. Clinica Chimica Acta, 298(1-2), 55-68.
35. Ruckert, I. M., Heier, M., Rathmann, W., Baumeister, S. E., Doring, A., & Meisinger, C. (2011). Association between markers of fatty liver disease and impaired glucose regulation in men and women from the general population: the KORA-F4-study. PLoS One, 6(8), e22932.
36. Seissler, J., Feghelm, N., Then, C., Meisinger, C., Herder, C., Koenig, W., et al. (2012). Vasoregulatory peptides pro-endothelin-1 and pro-adrenomedullin are associated with metabolic syndrome in the population-based KORA F4 study. European Journal of Endocrinology, 167(6), 847-853.
37. Silvestri, E., Lombardi, A., de Lange, P., Glinni, D., Senese, R., Cioffi, F., et al. (2011). Studies of complex biological systems with applications to molecular medicine: the need to integrate transcriptomic and proteomic approaches. Journal of Biomedicine and Biotechnology, 2011, 810242.
38. Suhre, K., Meisinger, C., Doring, A., Altmaier, E., Belcredi, P., Gieger, C., et al. (2010). Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS One, 5(11), e13953.
39. Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., et al. (2004). Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA, 291(2), 228-238.
40. Thienpont, L. M., van Uytfanghe, K., Beastall, G., Faix, J. D., Ieiri, T., Miller, W. G., et al. (2010). Report of the IFCC working group for standardization of thyroid function tests; part 2: free thyroxine and free triiodothyronine. Clinical Chemistry, 56(6), 912-920.
41. U. S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), & Center for Veterinary Medicine (CVM) (May 2001). Guidance for Industry - Bioanalytical Method Validation.
42. van Buuren, S., & Groothuis-Oudshoorn, K. (2011). Mice: multivariate imputation by chained equations in R. Journal of Statistical Software, 45(3), 1-67.
43. Vinayavekhin, N., & Saghatelian, A. (2009). Regulation of alkyl-dihydrothiazole-carboxylates (ATCs) by iron and the pyochelin gene cluster in Pseudomonasaeruginosa. ACS Chemical Biology, 4(8), 617-623.
44. Wagner, R. L., Apriletti, J. W., McGrath, M. E., West, B. L., Baxter, J. D., & Fletterick, R. J. (1995). A structural role for hormone in the thyroid hormone receptor. Nature, 378(6558), 690-697.
45. Watson, A. D. (2006). Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. Journal of Lipid Research, 47(10), 2101-2111.
46. Wenk, M. R. (2005). The emerging field of lipidomics. Nature Reviews Drug Discovery, 7, 594-610.
47. WHO. (2000). Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Technical Report Series, 894, 1-253.
48. Yen, P. M. (2001). Physiological and molecular basis of thyroid hormone action. Physiological Reviews, 81(3), 1097-1142.